Age, M (SD) |
60.8 (10.4) |
White, n (%) |
130 (94) |
Non-Hispanic/Latina, n (%) |
132 (96) |
College graduate, n (%) |
49 (35) |
Annual income >$40,000, n (%) |
73 (68) |
Stage of disease, n (%) |
|
I |
24 (19) |
II |
12 (10) |
III |
70 (55) |
IV |
21 (17) |
Gynecologic cancer diagnosis, n (%) |
|
Ovarian |
69 (49) |
Endometrial |
33 (24) |
Uterine |
15 (11) |
Peritoneal |
9 (7) |
Fallopian tube |
6 (4) |
Cervical |
5 (4) |
Vulvar |
1 (1) |
Other |
2 (2) |
Chemotherapy regimen, n (%) |
|
Intravenous |
126 (90) |
Intraperitoneal |
14 (10) |
Previous surgeries, n (%) |
|
0 |
29 (21) |
1 |
86 (62) |
2 |
15 (11) |
3+ |
8 (6) |
Previous lines of chemotherapy, n (%) |
|
0 |
86 (61) |
1 |
28 (20) |
2 |
12 (9) |
3+ |
14 (10) |
Previously received radiation therapy, n (%) |
7 (5) |